APA (7th ed.) Citation

J, B., S, A., KA, K., K, S., HW, L., E, L., . . . W, H. (2018). Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study. Leukemia, 32(12), 2558. https://doi.org/10.1038/s41375-018-0268-9

Chicago Style (17th ed.) Citation

J, Braess, et al. "Sequential High-dose Cytarabine and Mitoxantrone (S-HAM) Versus Standard Double Induction in Acute Myeloid Leukemia-a Phase 3 Study." Leukemia 32, no. 12 (2018): 2558. https://doi.org/10.1038/s41375-018-0268-9.

MLA (9th ed.) Citation

J, Braess, et al. "Sequential High-dose Cytarabine and Mitoxantrone (S-HAM) Versus Standard Double Induction in Acute Myeloid Leukemia-a Phase 3 Study." Leukemia, vol. 32, no. 12, 2018, p. 2558, https://doi.org/10.1038/s41375-018-0268-9.